Supplementary Figure S4 from Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure S4. Enzalutamide and KRLS-017 had no synergistic effect in AR-negative HCC1806 TNBC cells, and combination of enzalutamide and KRLS-017 reduced c-MYC transcription in AR+ LAR TNBC cells.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4411039223